Haddadin Yezan Munther
SEC CIK 1718004 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Dir | 66.2K | $118.2K | — | 5 | 2021-12-02 | 2026-06-02 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 18:03 | 2026-06-02 | OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Dir | P - Purchase | $0.8326 | +29.0K | 66.2K | +78% | +$24.1K | |
| 2026-05-27 15:24 | 2026-05-26 | OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Dir | P - Purchase | $0.44 | +34.0K | 37.2K | +1,074% | +$15.0K | |
| 2024-03-29 | 2024-03-28 | OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Dir | P - Purchase | $11.82 | +1,882 | 5,049 | +59% | +$22.2K | |
| M | 2022-10-11 | 2022-10-06+ | OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Dir | P - Purchase | $1.29 | +33.3K | 59.7K | +126% | +$42.9K |
| 2021-12-02 | 2021-12-02 | OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Dir | P - Purchase | $1.39 | +10.0K | 30.0K | +50% | +$13.9K |
Purchase Sale Sale after option exercise All abbreviations